Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro‐drug of miridesap-Reference-Cited by-同舟云学术

Identification, preclinical profile, and clinical proof of concept of an orally bioavailable pro‐drug of miridesap

Published:2020-02-11 Issue:8 Volume:177 Page:1853-1864
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Richards Duncan¹^ORCID,Bamford Mark¹,Liefaard Lia¹,Haque Nazneen¹^ORCID,Lewis Gareth²,Storey Jim¹,Fernando Disala³,Kumar Subramanya³,Thompson Douglas¹,Holmes Duncan S.¹

Affiliation:

1. GSK Research and DevelopmentGSK Stevenage Hertfordshire UK

2. GSK Research and DevelopmentGSK Ware Hertfordshire UK

3. GSK Clinical Unit Cambridge Cambridgeshire UK

Funder

GlaxoSmithKline

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14956

Reference20 articles.

1. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Introduction and Other Protein Targets

2. Antibodies to human serum amyloid P component eliminate visceral amyloid deposits

3. The Developability Classification System: Application of Biopharmaceutics Concepts to Formulation Development

4. Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers

5. Denis A. &Mirguet O.(2015).A prodrug of 1 1′‐(1 6‐dioxo‐1 6‐hexanediyl)bis‐d‐proline. PCT Int Appl: WO 2015165833 A1. Retrieved from:https://patentimages.storage.googleapis.com/bf/97/ab/618c026839eb4f/WO2015165833A1.pdf

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AA Amyloidosis: A Contemporary View;Current Rheumatology Reports;2024-04-03

2. Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management;Journal of Clinical Medicine;2024-03-18

3. Renal AA amyloidosis: presentation, diagnosis, and current therapeutic options: a review;Kidney International;2023-03